4th Quarter - Termination — ACG ADVOCACY for GENENTECH INC (2020)

Firm

ACG ADVOCACY

Client

GENENTECH INC

Income

$40,000

Expenses

—

Terminated

Dec 31, 2020

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing	Filed	Amount	Counted
4th Quarter - Report	Jan 14, 2021	$40,000	Replaced
4th Quarter - Termination (this page)	Feb 12, 2021	$40,000	Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Trade Negotiations. Trade Policy Issues.

Lobbyist	Covered position, as disclosed
DANA COLARULLI	—
CHRIS ISRAEL	—

Contacted: HOUSE OF REPRESENTATIVES; White House Office; Commerce, Dept of (DOC); SENATE

Copyright/Patent/Trademark CPT

General IP Issues. Patent Litigation Reform.

Lobbyist	Covered position, as disclosed
DANA COLARULLI	Director, Government Affairs PTO
CHRIS ISRAEL	U.S. Coordinator for International IP Enforcement; Deputy Chief of Staff, Department of Commerce; Deputy Assistant Secretary for Tech Policy, Department of Commerce.

Contacted: SENATE; Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; White House Office

Pharmacy PHA

Drug Pricing Issues. Public Health Crisis. H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security Act or the CARES Act.

Lobbyist	Covered position, as disclosed
CHRIS ISRAEL	—

Contacted: White House Office; Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 748 (116th), S. 3548 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.